Role of Soluble Urokinase-Type Plasminogen Activator Receptor in Cardiovascular Disease
Abstract Purpose of Review Chronic inflammation is a major contributor to cardiovascular
disease (CVD) risk. Soluble urokinase plasminogen activator receptor (suPAR) is an …
disease (CVD) risk. Soluble urokinase plasminogen activator receptor (suPAR) is an …
[HTML][HTML] Association between the Serum Soluble Urokinase Plasminogen Activator Receptor and Peripheral Arterial Stiffness According to the Cardio-Ankle Vascular …
HH Yang, YC Chen, CC Ho, BG Hsu - Reviews in Cardiovascular …, 2024 - imrpress.com
Background: High soluble urokinase plasminogen activator receptor (suPAR) levels are
correlated with cardiovascular (CV) disease. Arterial stiffness is associated with aging …
correlated with cardiovascular (CV) disease. Arterial stiffness is associated with aging …
[HTML][HTML] Serum Endocan Is a Risk Factor for Aortic Stiffness in Patients Undergoing Maintenance Hemodialysis
Background and Objectives: Endocan, secreted from the activated endothelium, is a key
player in inflammation, endothelial dysfunction, proliferation of vascular smooth muscle …
player in inflammation, endothelial dysfunction, proliferation of vascular smooth muscle …